Pre (n = 42) | Post (n = 37) | P value | |
---|---|---|---|
Women | 21 (50.0%) | 18 (48.6%) | |
Men | 21 (50.0%) | 19 (51.4%) | |
Age (years) | 49 (17–69) | 54 (13–67) | 0.34 |
Weight (kg) | 54 (36–90) | 61 (40–100) | 0.008 |
Height (m) | 1.65 (1.42–1.83) | 1.65 (1.55–1.87) | 0.37 |
BMI (kg/m2) | 18.9 (14.8–34.0) | 22.1 (16.0–61.0) | 0.002 |
Creatinine (μM) | 69 (29–96) | 61 (31–136) | 0.96 |
CMV positivity | 18 (42.9%) | 15 (40.5%) | 0.84 |
Pulmonary hypertensiona | 4 (9.5%) | 5 (13.5%) | 0.58 |
Diagnosis | 0.57 | ||
CF | 18 (42.9%) | 11 (29.7%) | |
COPD | 9 (21.4%) | 10 (27.0%) | |
AAT | 2 (4.8%) | 3 (8.1%) | |
IPF | 9 (21.4%) | 11 (29.7%) | |
PAH | 1 (2.4%) | 0 (0%) | |
Other | 3 (7.1%) | 2 (5.4%) | |
Location before TPL | 0.26 | ||
Home | 34 (81.0%) | 29 (78.4%) | |
Hospital, ward | 6 (14.3%) | 4 (10.8%) | |
Hospital, ICU | 2 (4.7%) | 4 (10.8%) | |
ECMO support before TPL | 0 (0%) | 3 (8.1%) | 0.06 |
Mechanical ventilation before TPL | 1 (4.8%) | 4 (10.8%) | 0.31 |